Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.6%

34 terminated/withdrawn out of 612 trials

Success Rate

87.9%

+1.4% vs industry average

Late-Stage Pipeline

17%

104 trials in Phase 3/4

Results Transparency

6%

14 of 247 completed trials have results

Key Signals

134 recruiting14 with results28 terminated6 withdrawn

Enrollment Performance

Analytics

N/A
198(47.8%)
Phase 4
67(16.2%)
Phase 2
67(16.2%)
Phase 1
42(10.1%)
Phase 3
37(8.9%)
Early Phase 1
3(0.7%)
414Total
N/A(198)
Phase 4(67)
Phase 2(67)
Phase 1(42)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (612)

Showing 20 of 612 trials
NCT07640373Not ApplicableNot Yet Recruiting

Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis

Role: collaborator

NCT05640999Phase 2Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Role: collaborator

NCT06394999Phase 3Active Not Recruiting

Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive

Role: lead

NCT05186064Not ApplicableCompleted

Glioblastoma Targeted Treatment Option Maximization by WGS

Role: collaborator

NCT07624786Not Yet Recruiting

Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

Role: collaborator

NCT07621029Not Yet Recruiting

Venous Resection in Patients Undergoing Pancreatic Surgery

Role: collaborator

NCT05529927Phase 2Recruiting

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Role: collaborator

NCT07605754Recruiting

Results of Nerve Surgery to Treat PostAmputation Pain

Role: lead

NCT05546372Not ApplicableRecruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Role: collaborator

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Role: collaborator

NCT05255653Phase 2Recruiting

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

Role: lead

NCT06367829Enrolling By Invitation

Lubinus SPII Hip Stem Target Trial Emulation

Role: collaborator

NCT05689190Terminated

Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD)

Role: collaborator

NCT06805396Phase 2Recruiting

Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: A Randomized Trial

Role: collaborator

NCT05123963Not ApplicableRecruiting

Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors

Role: collaborator

NCT07558174Recruiting

SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging

Role: lead

NCT06757543Not ApplicableRecruiting

A Stepped Wedge Cluster Randomised Trial Of Video Versus Direct Laryngoscopy For Intubation Of Newborn Infants

Role: collaborator

NCT01558921Phase 3Active Not Recruiting

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

Role: collaborator

NCT07546669Phase 4Not Yet Recruiting

Efficacy of Zoster Vaccination in Glioblastoma Patients

Role: collaborator

NCT04071704Completed

Assessing Health-related Quality of Life in Sarcoma Patients

Role: collaborator